Safety and efficacy of blood glucose management practices at a diabetes camp

Hasantha Gunasekera1, Geoffrey Ambler

  • 1Children's Hospital at Westmead, Sydney, New South Wales, Australia. hasanthg@chw.edu.au

Insights

Diabetes camps can be safe and effective for children with diabetes. Careful monitoring and management guidelines help prevent serious adverse events like severe hypoglycemia.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Management
  • Camp Health

Background:

  • Summer camps are vital for children with diabetes, but safety and efficacy data are limited.
  • Effective blood glucose management in pediatric diabetes camps requires specific guidelines.

Purpose of the Study:

  • To assess the safety and efficacy of established blood glucose management guidelines at diabetes summer camps for children.
  • To analyze glucose variability, insulin dosage, and adverse events during camp.

Main Methods:

  • Implemented consistent management guidelines over 10 consecutive diabetes camps (1998-2002).
  • Analyzed insulin dosage, hypoglycemia (<4 mmol/L), hyperglycemia (>15 mmol/L), and ketosis in campers aged 9-13.
  • Evaluated overnight management protocols and factors influencing hypoglycemia frequency.

Main Results:

  • Mean insulin doses decreased by 19.2% by day 6 of camp.
  • Blood glucose levels showed variability, with 9.1% of readings below 4 mmol/L and 23.7% above 15 mmol/L.
  • No severe hypoglycemia (grade 3) occurred; hypoglycemia frequency was independent of various factors.

Conclusions:

  • Children with diabetes experience significant blood glucose variability at camp.
  • Careful application of monitoring and management guidelines is effective in preventing serious adverse events.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...